|Articles|February 9, 2004
Innovation comes to wound products and therapies
The competition among dermal substitute manufacturers to meet the needsof a burgeoning population of chronic wound sufferers has resulted in agrowth market of continually improving products, according to Eliot N. Mostow,M.D., an Akron, Ohio, dermatologist and wound care specialist. The escalationof diabetes and diabetes-related wounds, along with an aging population,are just two factors influencing this trend, he said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













